{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:44:56Z","timestamp":1782193496577,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aortic dilatation (AD) occurs in up to 30% of patients with giant cell arteritis (GCA). Reliable biomarkers for AD development, however, are still absent. The aim of this exploratory study was to evaluate whether immunological parameters are associated with the occurrence of AD in GCA. Cross-sectional study on 20 GCA patients with AD, 20 GCA patients without AD, and 20 non-GCA controls without AD measuring leukocytes, neutrophils, lymphocytes, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum amyloid A (SAA), interferon (IFN)-\u03b1, IFN-\u03b3, IFN-\u03b3-induced protein 10 (IP-10), interleukin (IL) 5, IL-8, IL-10, IL-17A, IL-18, IL-1 receptor antagonist, tumor necrosis factor (TNF)-\u03b1, platelet-derived growth factor (PDGF), L-selectin, P-selectin, and soluble intercellular adhesion molecule 1 (sICAM-1). AD was measured by aortic contrast-enhanced computed tomography and defined by enlargement of the aorta above population-based aortic diameters adjusted by age, gender, and body surface area. No significant differences were observed between GCA patients with AD and GCA patients without AD concerning levels of leukocytes, neutrophils, lymphocytes, CRP, ESR, SAA, IL-8, IL-18, PDGF, IP-10, selectins, and sICAM-1. Values of IFN-\u03b1, IFN-\u03b3, IL-5, IL-10, IL-17A, IL-1 receptor antagonist, and TNF-\u03b1 were all below the detection limits in more than 70% of subjects. Lymphocytes and CRP revealed positive correlations with the diameter of the thoracic descending aorta. Immunological parameters were not useful to conclude on the presence of AD in GCA. Further studies are required to test if CRP and lymphocytes may be useful to predict future development of AD in GCA.<\/jats:p>","DOI":"10.1007\/s00296-022-05186-1","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T03:40:42Z","timestamp":1661226042000},"page":"477-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of immunological parameters with aortic dilatation in giant cell arteritis: a cross-sectional study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0832-1322","authenticated-orcid":false,"given":"Philipp","family":"Jud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-4056","authenticated-orcid":false,"given":"Nicolas","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-6626","authenticated-orcid":false,"given":"Martin H.","family":"Stradner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-0668","authenticated-orcid":false,"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-0166","authenticated-orcid":false,"given":"Dieter","family":"Szolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-3679","authenticated-orcid":false,"given":"Ren\u00e9","family":"Thonhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Schweiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-3799","authenticated-orcid":false,"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"5186_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","volume":"13","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC et al (2017) Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol 13:578\u2013592","journal-title":"Nat Rev Rheumatol"},{"key":"5186_CR2","first-page":"506","volume":"56","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F et al (2017) The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford) 56:506\u2013515","journal-title":"Rheumatology (Oxford)"},{"key":"5186_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2012-202145","volume":"73","author":"SL Mackie","year":"2014","unstructured":"Mackie SL, Hensor EM, Morgan AW et al (2014) Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann Rheum Dis 73:143\u2013148","journal-title":"Ann Rheum Dis"},{"key":"5186_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/annrheumdis-2013-204113","volume":"74","author":"JC Robson","year":"2015","unstructured":"Robson JC, Kiran A, Maskell J et al (2015) The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis 74:129\u2013135","journal-title":"Ann Rheum Dis"},{"key":"5186_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","volume":"83","author":"MA Gonzalez-Gay","year":"2004","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Pi\u00f1eiro A et al (2004) Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 83:335\u2013341","journal-title":"Medicine (Baltimore)"},{"key":"5186_CR6","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.11353","volume":"48","author":"DM Nuenninghoff","year":"2003","unstructured":"Nuenninghoff DM, Hunder GG, Christianson TJ et al (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48:3522\u20133531","journal-title":"Arthritis Rheum"},{"key":"5186_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.semarthrit.2020.11.003","volume":"15","author":"P Jud","year":"2021","unstructured":"Jud P, Verheyen N, Dejaco C et al (2021) Prevalence and prognostic factors for aortic dilatation in giant cell arteritis - a longitudinal study. Semin Arthritis Rheum 15:911\u2013918","journal-title":"Semin Arthritis Rheum"},{"key":"5186_CR8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","volume":"72","author":"TA Kermani","year":"2013","unstructured":"Kermani TA, Warrington KJ, Crowson CS et al (2013) Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 72:1989\u20131994","journal-title":"Ann Rheum Dis"},{"key":"5186_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","volume":"54","author":"B Baslund","year":"2015","unstructured":"Baslund B, Helleberg M, Faurschou M et al (2015) Mortality in patients with giant cell arteritis. Rheumatology (Oxford) 54:139\u2013143","journal-title":"Rheumatology (Oxford)"},{"key":"5186_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/rheumatology\/key028","volume":"57","author":"A Aouba","year":"2018","unstructured":"Aouba A, Gonzalez Chiappe S, Eb M et al (2018) Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980\u20132011). Rheumatology (Oxford) 57:1047\u20131055","journal-title":"Rheumatology (Oxford)"},{"key":"5186_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03009742.2020.1786855","volume":"50","author":"MJ Koster","year":"2021","unstructured":"Koster MJ, Crowson CS, Labarca C et al (2021) Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis. Scand J Rheumatol 50:239\u2013242","journal-title":"Scand J Rheumatol"},{"key":"5186_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/art.23315","volume":"59","author":"A Garc\u00eda-Mart\u00ednez","year":"2008","unstructured":"Garc\u00eda-Mart\u00ednez A, Hern\u00e1ndez-Rodr\u00edguez J, Arguis P et al (2008) Development of aortic aneurysm\/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 59:422\u2013430","journal-title":"Arthritis Rheum"},{"key":"5186_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003210","volume":"95","author":"A Hocevar","year":"2016","unstructured":"Hocevar A, Rotar Z, Jese R et al (2016) Do early diagnosis and glucocorticoid treatment decrease the risk of permanent visual loss and early relapses in giant cell arteritis: a prospective longitudinal study. Medicine (Baltimore) 95:e3210","journal-title":"Medicine (Baltimore)"},{"key":"5186_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128","journal-title":"Arthritis Rheum"},{"key":"5186_CR15","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/art.39217","volume":"67","author":"L O'Neill","year":"2015","unstructured":"O\u2019Neill L, Rooney P, Molloy D et al (2015) Regulation of inflammation and angiogenesis in giant cell arteritis by acute-phase serum amyloid A. Arthritis Rheumatol 67:2447\u20132456","journal-title":"Arthritis Rheumatol"},{"key":"5186_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.autrev.2017.11.022","volume":"17","author":"B Burja","year":"2018","unstructured":"Burja B, Kuret T, Sodin-Semrl S et al (2018) A concise review of significantly modified serological biomarkers in giant cell arteritis, as detected by different methods. Autoimmun Rev 17:188\u2013194","journal-title":"Autoimmun Rev"},{"key":"5186_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3899\/jrheum.190093","volume":"47","author":"A Rodriguez-Pla","year":"2020","unstructured":"Rodriguez-Pla A, Warner RL, Cuthbertson D et al (2020) Evaluation of potential serum biomarkers of disease activity in diverse forms of vasculitis. J Rheumatol 47:1001\u20131010","journal-title":"J Rheumatol"},{"key":"5186_CR18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/keu526","volume":"54","author":"KS van der Geest","year":"2015","unstructured":"van der Geest KS, Abdulahad WH, Rutgers A et al (2015) Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica. Rheumatology (Oxford) 54:1397\u20131402","journal-title":"Rheumatology (Oxford)"},{"key":"5186_CR19","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/art.34327","volume":"64","author":"B Terrier","year":"2012","unstructured":"Terrier B, Geri G, Chaara W et al (2012) Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis. Arthritis Rheum 64:2001\u20132011","journal-title":"Arthritis Rheum"},{"key":"5186_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/art1.10161","volume":"47","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2002","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J, Garc\u00eda-Mart\u00ednez A, Casademont J et al (2002) A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum 47:29\u201335","journal-title":"Arthritis Rheum"},{"key":"5186_CR21","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/rheumatology\/ker163","volume":"50","author":"S Visvanathan","year":"2011","unstructured":"Visvanathan S, Rahman MU, Hoffman GS et al (2011) Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis\u2013a prospective longitudinal study. Rheumatology (Oxford) 50:2061\u20132070","journal-title":"Rheumatology (Oxford)"},{"key":"5186_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/ard.58.3.189","volume":"58","author":"B Coll-Vinent","year":"1999","unstructured":"Coll-Vinent B, Vilardell C, Font C et al (1999) Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Ann Rheum Dis 58:189\u2013192","journal-title":"Ann Rheum Dis"},{"key":"5186_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.ajpath.2011.11.028","volume":"180","author":"K Isoda","year":"2012","unstructured":"Isoda K, Kitagaki M, Niida T et al (2012) Deficiency of interleukin-1 receptor antagonist promotes spontaneous femoral artery aneurysm formation in mice. Am J Pathol 180:1254\u20131263","journal-title":"Am J Pathol"},{"key":"5186_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jss.2011.12.016","volume":"178","author":"J Xu","year":"2012","unstructured":"Xu J, Ehrmann B, Graham LM et al (2012) Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice. J Surg Res 178:512\u2013518","journal-title":"J Surg Res"},{"key":"5186_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.105.535625","volume":"112","author":"KK Hannawa","year":"2005","unstructured":"Hannawa KK, Eliason JL, Woodrum DT et al (2005) L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 112:241\u2013247","journal-title":"Circulation"},{"key":"5186_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2019.08.003","volume":"289","author":"C Suehiro","year":"2019","unstructured":"Suehiro C, Suzuki J, Hamaguchi M et al (2019) Deletion of interleukin-18 attenuates abdominal aortic aneurysm formation. Atherosclerosis 289:14\u201320","journal-title":"Atherosclerosis"},{"key":"5186_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1196\/annals.1383.014","volume":"1085","author":"KK Hannawa","year":"2006","unstructured":"Hannawa KK, Cho BS, Sinha I et al (2006) Attenuation of experimental aortic aneurysm formation in P-selectin knockout mice. Ann N Y Acad Sci 1085:353\u2013359","journal-title":"Ann N Y Acad Sci"},{"key":"5186_CR28","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.amjcard.2013.01.306","volume":"111","author":"IS Rogers","year":"2013","unstructured":"Rogers IS, Massaro JM, Truong QA et al (2013) Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study). Am J Cardiol 111:1510\u20131516","journal-title":"Am J Cardiol"},{"key":"5186_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jvs.2010.05.090","volume":"52","author":"KC Kent","year":"2010","unstructured":"Kent KC, Zwolak RM, Egorova NN et al (2010) Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 52:539\u2013548","journal-title":"J Vasc Surg"},{"key":"5186_CR30","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","volume":"35","author":"R Erbel","year":"2014","unstructured":"Erbel R, Aboyans V, Boileau C et al (2014) 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35:2873\u20132926","journal-title":"Eur Heart J"},{"key":"5186_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jcmg.2007.11.005","volume":"1","author":"A Wolak","year":"2008","unstructured":"Wolak A, Gransar H, Thomson LE et al (2008) Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area. JACC Cardiovasc Imaging 1:200\u2013209","journal-title":"JACC Cardiovasc Imaging"},{"key":"5186_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","volume":"121","author":"J Deng","year":"2010","unstructured":"Deng J, Younge BR, Olshen RA et al (2010) Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121:906\u2013915","journal-title":"Circulation"},{"key":"5186_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.avsg.2017.05.024","volume":"45","author":"Z Shangwei","year":"2017","unstructured":"Shangwei Z, Yingqi W, Jiang X et al (2017) Serum high-sensitive C-reactive protein level and CRP genetic polymorphisms are associated with abdominal aortic aneurysm. Ann Vasc Surg 45:186\u2013192","journal-title":"Ann Vasc Surg"},{"key":"5186_CR34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12872-019-1267-0","volume":"19","author":"Y He","year":"2019","unstructured":"He Y, Ma C, Xing J et al (2019) Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection. BMC Cardiovasc Disord 19:282","journal-title":"BMC Cardiovasc Disord"},{"key":"5186_CR35","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/heartjnl-2013-304158","volume":"99","author":"D Wen","year":"2013","unstructured":"Wen D, Du X, Dong JZ et al (2013) Value of D-dimer and C reactive protein in predicting inhospital death in acute aortic dissection. Heart 99:1192\u20131197","journal-title":"Heart"},{"key":"5186_CR36","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/bjs.9593","volume":"101","author":"PW Stather","year":"2014","unstructured":"Stather PW, Sidloff DA, Dattani N et al (2014) Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg 101:1358\u20131372","journal-title":"Br J Surg"},{"key":"5186_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cca.2018.08.005","volume":"486","author":"T Zeng","year":"2018","unstructured":"Zeng T, Shi L, Ji Q et al (2018) Cytokines in aortic dissection. Clin Chim Acta 486:177\u2013182","journal-title":"Clin Chim Acta"},{"key":"5186_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.108.785949","volume":"119","author":"VL King","year":"2009","unstructured":"King VL, Lin AY, Kristo F et al (2009) Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation 119:426\u2013435","journal-title":"Circulation"},{"key":"5186_CR39","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.humpath.2006.03.017","volume":"37","author":"V Lesauskaite","year":"2006","unstructured":"Lesauskaite V, Epistolato MC, Castagnini M et al (2006) Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Hum Pathol 37:1076\u20131084","journal-title":"Hum Pathol"},{"key":"5186_CR40","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.athoracsur.2015.05.009","volume":"100","author":"NH Pope","year":"2015","unstructured":"Pope NH, Salmon M, Johnston WF et al (2015) Interleukin-6 receptor inhibition prevents descending thoracic aortic aneurysm formation. Ann Thorac Surg 100:1620\u20131626","journal-title":"Ann Thorac Surg"},{"key":"5186_CR41","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/01.ATV.0000167520.41436.c0","volume":"25","author":"C Duftner","year":"2005","unstructured":"Duftner C, Seiler R, Klein-Weigel P et al (2005) High prevalence of circulating CD4+CD28- T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 25:1347\u20131352","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5186_CR42","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/art.11243","volume":"48","author":"GS Hoffman","year":"2003","unstructured":"Hoffman GS (2003) Large-vessel vasculitis: unresolved issues. Arthritis Rheum 48:2406\u20132414","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05186-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T08:05:20Z","timestamp":1677312320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05186-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["5186"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05186-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"9 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}